Gait Metric Validation of the Cionic Neural Sleeve
Launched by CIONIC, INC. · Jul 9, 2024
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a device called the Cionic Neural Sleeve, which is designed to help people improve their walking ability. Researchers want to see if the information about walking patterns (called gait metrics) provided by the Neural Sleeve is accurate when compared to a well-established method using a special pressure-sensitive walkway. This comparison will help determine if the data from the Neural Sleeve can be trusted, which could be very helpful for people using the device. If the metrics are accurate, users can feel confident in using the device to track their walking improvements. If not, it will be important to understand the limitations of the device.
To participate in this study, individuals must be between 22 and 64 years old and able to walk for at least 30 minutes within a two-hour timeframe. Those with certain medical conditions, such as serious leg injuries or specific diseases affecting nerve function, will not be eligible. Participants can expect to take part in assessments that measure their walking patterns while using the Neural Sleeve and will play an important role in helping to improve the device for future users. The study is currently looking for volunteers, and all genders are welcome to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persons between the ages of 22-64
- • Ability to ambulate at least 30 minutes during a two hour period
- Exclusion Criteria:
- • Lower motor neuron disease or injury (e.g. peripheral neuropathy)
- • Absent sensation in the legs
- • Demand-type cardiac pacemaker or defibrillator
- • Malignant tumor in the legs
- • Existing thrombosis in the legs
- • History of lower limb injury or orthopedic issues leading to impaired walking
About Cionic, Inc.
Cionic, Inc. is a pioneering medical technology company focused on developing innovative neurotechnology solutions aimed at enhancing mobility and improving the quality of life for individuals with neurological conditions. With a commitment to advancing healthcare through cutting-edge research and development, Cionic combines expertise in biomechanics, neuroscience, and engineering to create wearable devices and therapies that facilitate improved motor function and rehabilitation. The company’s clinical trials are designed to rigorously evaluate the efficacy and safety of its products, positioning Cionic as a leader in the intersection of technology and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported